FDCC
MRNA icon

Foster Dykema Cabot & Co’s Moderna MRNA Stock Holding History

Foster Dykema Cabot & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1K Hold
10
– – ﹤0.01% 316
2023
Q2 		$1K Hold
10
– – ﹤0.01% 377
2023
Q1 		$2K Buy
+10
New +$1.65K ﹤0.01% 227

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Foster Dykema Cabot & Co's MRNA Position: Q3 2023 in Review

Foster Dykema Cabot & Co held its Moderna (MRNA) position steady in Q3 2023 at 10 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #316.

Foster Dykema Cabot & Co first reported a position in MRNA in Q1 2023 and has held it in 3 quarters since. The position peaked at $2K in Q1 2023. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Foster Dykema Cabot & Co held 10 shares of Moderna worth $1K as of Q3 2023.
  • Foster Dykema Cabot & Co left its Moderna share count unchanged in Q3 2023.
  • Moderna made up ﹤0.01% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #316 holding.
  • Foster Dykema Cabot & Co first reported a position in Moderna in Q1 2023 and has held it in 3 quarters since.
  • Foster Dykema Cabot & Co's Moderna position peaked at $2K in Q1 2023.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.